Geode Capital Management, LLC Aveo Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$8.48 - $14.97 $64,261 - $113,442
7,578 Added 2.82%
275,892 $4.12 Million
Q3 2022

Nov 14, 2022
SELL
$6.61 - $8.72 $103,479 - $136,511
-15,655 Reduced 5.51%
268,314 $2.21 Million
Q2 2022

Aug 12, 2022
BUY
$3.51 - $6.67 $53,650 - $101,950
15,285 Added 5.69%
283,969 $1.86 Million
Q1 2022

May 13, 2022
BUY
$3.15 - $6.01 $30,299 - $57,810
9,619 Added 3.71%
268,684 $1.5 Million
Q4 2021

Feb 11, 2022
BUY
$4.69 - $7.4 $42,660 - $67,310
9,096 Added 3.64%
259,065 $1.22 Million
Q3 2021

Nov 12, 2021
BUY
$5.12 - $6.89 $22,138 - $29,792
4,324 Added 1.76%
249,969 $1.54 Million
Q2 2021

Aug 13, 2021
SELL
$6.21 - $7.45 $945,733 - $1.13 Million
-152,292 Reduced 38.27%
245,645 $1.62 Million
Q1 2021

May 12, 2021
BUY
$5.97 - $15.28 $461,254 - $1.18 Million
77,262 Added 24.09%
397,937 $2.91 Million
Q4 2020

Feb 12, 2021
BUY
$5.08 - $6.68 $217,952 - $286,598
42,904 Added 15.45%
320,675 $1.85 Million
Q3 2020

Nov 13, 2020
BUY
$4.16 - $6.26 $344,219 - $517,983
82,745 Added 42.43%
277,771 $1.65 Million
Q2 2020

Aug 13, 2020
BUY
$3.47 - $9.99 $338,071 - $973,295
97,427 Added 99.82%
195,026 $1 Million
Q1 2020

May 14, 2020
BUY
$2.6 - $6.9 $253,757 - $673,433
97,599 New
97,599 $353,000

Others Institutions Holding AVEO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AVEO PHARMACEUTICALS, INC.

AVEO Quotes by TradingView
  • Ticker AVEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,676,000
  • Description
  • AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...
More about AVEO
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email